Welcure Drugs & Pharmaceuticals Ltd posts robust Q1FY26 performance with Rs 23.29 crore net profit
New Delhi [India], August 6: Welcure Drugs & Pharmaceuticals Ltd (BSE: 524661), today announced its financial results for the quarter ended June 30, 2025 (Q1FY26). The company has reported a robust financial performance in the first quarter of FY26, driven by its strategic foray into fee-based, export-oriented sourcing services. Welcure’s revenue from operations rose sharply to…